Cancer research
Breakthrough in Cancer Gene Therapy: Overcoming Immune Resistance in Advanced Esophageal Squamous Cell Carcinoma
Researchers at the Affiliated People's Hospital in Fujian, People's Republic of China, have reported a significant breakthrough in cancer gene therapy, using a genetically modified oncolytic adenovirus called H101 to treat advanced esophageal squamous cell carcinoma (ESCC). The study, published in Frontiers in Immunology, demonstrated the